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In  recent  years,  many  interesting  results  have  been  reported  by  investigators 
attempting to identify antigen receptors on T  cells, but there has been limited success 
in the characterization  of these molecules.  Most efforts have focused on T  cells or T 
cell products that have been demonstrated to bind free antigen (Ag), because in these 
cases an easily definable  function could be used  to assay any likely candidates  that 
were  identified.  Using  material  of this  kind,  it  has  been  suggested  that  T  cell  Ag 
receptors bear determinants  that are cross-reactive with antibody idiotypes or VH (1- 
12) and which also map to the major histocompatibility complex (MHC) t  (7,  13-16). 
In addition,  antisera  raised  against  surface proteins  on' T  cells, especially suppressor 
T  cells,  have  suggested  that  determinants  mapping  near  Igh  are  displayed  on  the 
surfaces of some types of T  cells and are intimately  involved with Ag recognition by 
these cells (17-19). 
T  cell  products  have been isolated  using their  ability  to bind  Ag and  the various 
antisera mentioned above, and thus some preliminary biochemical data are available 
concerning these products. These proteins, usually suppressor factors, have molecular 
weights of ~70,000  (20-23), although smaller molecules have been reported (16). The 
70,000-tool wt proteins have been shown to be susceptible to proteolytic cleavage into 
smaller  subunits  of 25-30,000  and  45-50,000  mol  wt  (20-23);  the  larger  fragment 
possesses apparent functional activity and the smaller subunit may be the Ag-binding 
portion,  although  this  may not always be so. The Ag-binding protein  of 70,000 has 
been demonstrated  to be a  soluble factor secreted by suppressor T  cells, but has also 
been  identified  in  association  with  other  T  cell  populations.  The  role  of MHC 
products in Ag recognition by these structures  is not clear. 
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l Abbreviations used in  this paper." BSS, balanced  salt solution; cOVA,  chicken ovalbumin;  Con  A, 
concanavalin A; HAT, hypoxanthine-aminopterin-thymidine; HgG, human gamma globulin; IL-2, inter- 
leukin  2; jfOVA, jungle  fowl ovalbumin;  MHC,  major  histocompatibility complex; PBS, phosphate- 
buffered saline; qOVA, quail ovalbumin; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis; [aH]TdR, tritiated thymidine; tOVA, turkey ovalbumin; (TG)AL, poly-L(Tyr,  Glu)-poly-D,L-Ala- 
-poly-t.-Lys;  wOVA, widgeon ovalbumin. 
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Biochemical experiments dealing with MHC-restricted receptors for Ag (Ag/MHC 
receptors)  on  T  cells have  been  less  fruitful.  Although  there  are  some  reports  that 
these are structurally analogous to receptors that bind free Ag (6), this is by no means 
universally acknowledged. Our own experiments, and those of others (24  26), suggest 
that  recognition of MHC  products and Ag does not occur via independent receptors 
on  T  cell surfaces.  Although  there are suggestions that  part  of these  receptors may 
map  near  Igh  (27),  we  have  failed  to  inhibit  Ag/MHC  recognition  with  anti-VH 
reagents, and  moreover, Ag/MHC  receptors do not seem to be encoded on chromo- 
somes coding for light chains or the MHC  itself (28; and N. R. Roehm, K. Karjalainen, 
J.  Kappler, and P.  Marrack, manuscript  in preparation). To resolve this dichotomy, 
we set out to study T  cell receptors for Ag/MHC  in a  more direct fashion by raising 
monoclonal antibodies against these receptors on cloned T  cell hybridomas. We have 
reported elsewhere (29)  on  the properties of antisera raised in congenic mice against 
Ag/MHC-specific T  cell hybridomas.  These  antisera  were  determined  to  be  highly 
specific  in  their  ability to  block  Ag/MHC  recognition  by  the  immunogen  T  cell 
hybrid but not by other closely related T  cell hybridomas. 
In  this paper we  describe a  monoclonal  antibody obtained  from  spleen cells of a 
mouse that had produced high titers of inhibitory antisera. Like the antiserum of the 
mouse from which it was derived, this monoclonal antibody interferes with Ag/MHC 
recognition  by  the  immunizing  T  cell  hybridoma,  but  no  other.  The  molecule 
recognized  by  this  monoclonal  antibody  has  an  apparent  molecular  weight,  as 
determined  by  sodium  dodecyl  sulfate-polyacrylamide  gel  electrophoresis  (SDS- 
PAGE)  analysis, of 80-90,000  under  nonreducing conditions and  of 40-44,000  after 
reduction, which suggests that a  molecule with these biochemical properties is closely 
involved in Ag/MHC  recognition by T  cells. 
Materials  and  Methods 
Mice.  All mice were bred in our facilities at National .Jewish Hospital from breeding stock 
originally obtained  from  various individuals and  suppliers as  follows: BALB/cBy, AKR/J, 
C57BL10/SgSn,  B10.A, and  DBA/2J, The Jackson  Laboratory, Bar Harbor, ME;  BALB.B, 
Dr.  Michael Bevan, Scripps Clinic and  Research  Foundation, La Jolla, CA; C.B20,  Dr.  Ian 
Zitron, Thomas Jefferson University, Philadelphia, PA. 
Culture Conditions.  All cultures were performed in modified Mishell-Dutton medium (24, 30) 
supplemented with  10% fetal calf serum and 5 ×  10 -5 M  2-mercaptoethanol. 
Antigens.  Chicken (c) and turkey (t) ovalbumin (OVA) and human gamma globulin (HgG) 
were obtained from the Sigma Chemical Co., St. Louis, MO.  Po]y-L-(Tyr,Glu)-poly-D,L-Ala-- 
poly-L-Lys [(TG)AL] was obtained from Miles Laboratories Inc., Elkhart, IN. Jungle fowl (if), 
quail (q), and widgeon (w) OVA were prepared in our laboratory by standard techniques (31) 
from eggs obtained from the Denver Zoo and CQF Manufacturing Co., Savannah, GA. 
T  Cell Hybridomas.  The  T  cell  hybridomas  used  in  these  studies  were  produced  and 
characterized as previously described (24, 32). Briefly, T cell Masts enriched in antigen-specific 
cells were fused to an azaguanine-resistant T  cell tumor (usually BW5147) using polyethylene 
glycol 1540. Hybrids were selected in hypoxanthine-aminopterin-thymidine (HAT)-conlaining 
medium  and  screened  for their ability to secrete interleukin 2  (IL-2) when  stimulated with 
antigen in the presence of Ag-presenting cells of the appropriate H-2 type. Hybrids with high 
reactivity were cloned at limiting dilution. The antigen and I region specificities of the hybrids 
were determined using several antigens and Ag-presenting cells from a bank of H-2 congenic 
and recombinant mice. Specificities were confirmed by inhibition of antigen presentation with 
monoclonal anti-Ia antibodies. Table I lists the cloned T  cell hybridomas used in these studies 
with their relevant properties. The T  cell hybridoma DO-11.10 responded to cOVA/I-A  d and 
cross-reacted with jtOVA/I-A  d and cOVA/I-A  h. Although three T  cell hybridomas shown in HASKINS  ET  AL.  1151 
Table I share with DO- 11.10 the property of recognizing cOVA/I-A  d, their receptors are clearly 
different, as they show different fine specificities when their ability to respond to various OVA 
and I-A products is measured. 
IL-2 Production and Assay.  The ability of T  cell hybridomas to be stimulated to produce IL- 
2  was  assessed  as  previously  described  with  a  few  modifications  (24,  28,  32).  Briefly,  250-#1 
cultures were prepared containing limiting numbers of hybridoma T  cells (1.25 ×  104/cuhure), 
100-200 #~ of antigen, and either 1 ×  106 irradiated (4,000 rad from a  laTCs source) spleen cells 
or  1 ×  10  A20-2J BALB/c B  lymphoma cells  (33,  34)  as Ag-presenting cells.  After 24 h  the 
culture supernates were assayed in  100-#l twofold dilutions for the presence of IL-2 using the 
IL-2-dependent  T  cell  line  HT-2  (kindly  provided  by  Dr.  James  Watson,  University  of 
Auckland, New Zealand)  (35). A  unit of IL-2 was defined as that amount present in the first 
twofold dilution in which the viability of HT-2  dropped  below 90% after 24 h.  Results were 
reported as units of IL-2 per milliliter of culture supernate,  l0 U/ml was the minimum amount 
detectable. 
Immunizations.  Mice were immunized with 2 ×  107 irradiated (4,000 rad from a 13VCs source) 
hybridoma T  cells intraperitoneally in balanced salt solution (BSS). Immunizations were given 
weekly for 4-6 wk. Thereafter, immunizations were given biweekly and on alternate weeks the 
mice were bled and antisera assayed individually for putative anti-Ag/MHC receptor antibodies 
(see below). Animals selected for fusions were rested 4 wk before receiving a final immunization 
intravenously 3 d  before fusion. 
B Cell Fusion Procotol.  Mice selected for fusions were killed 3 d  after a  final injection of the 
immunogen  T  cell  hybridoma.  Spleen  cell  suspensions were  prepared,  washed  in  BSS,  and 
treated  with anti-T cell serum  and rabbit or guinea pig complement  to  deplete T  cells  (36). 
The remaining spleen cells were mixed with washed P3-X63 Ag8.653 myeloma cells in a  ratio 
of ~5:1 spleen cells to P3. After pelleting, the mixed cells were resuspended over the course of 
1 min in  1 ml of a  40% solution of polyethylene glycol 6000, prewarmed to 37°C. The mixture 
was incubated at 37°C for 1 rain, warm medium was then added dropwise to a  final volume of 
20 ml, and the mixture was incubated for 10 min at 37°C. The fused cells were gently washed, 
resuspended in medium containing 4,000-rad-irradiated spleen cells (3 ×  106), and then plated 
out into 8-12 96-well microcuhure plates. After 24 h HAT was added and thereafter the culture 
medium was changed about every 5 d. The culture supernatants froni wells positive for hybrid 
growth were tested for the presence of putative anti-receptor antibodies as described below. 
Assay for Antibodies against Ag/MHC Receptors.  Antibodies from immunized animals or from 
the supernatants of B cell hybridomas were assayed for activity against Ag/MHC  receptors on 
T  cells by two methods (29). The first method assumed that anti-Ag/MHC receptor antibodies 
might  mimic  the action of Ag/MHC.  Antibodies were  therefore assayed  for their ability  to 
stimulate IL-2 production by Ag/MHC-specific T  cell hybridomas in the absence of any other 
activation  signal.  So  far,  we  have  not  identified  any  antibody  of  this  type  in  antisera  or 
TABLE  I 
T Cell Hybridomas Used in These Studies 
Fusion partners  Specificity 
T cell hy-  Normal T cell 
bridoma  Tumor cell  Ag/Self-I  Other 
Strain  Ag  I:t-2 
DO- 11.10  BALB/c  cOVA  d  BW5147  eOVA/I-A  d  cOVA/I-A  b, j fOVA/I-A  d 
3DO-36.6  BALB/c  cOVA  d  BW5147  cOVA/I-E  d  jfOVA/I-E  d, tOVA/I-E  d 
3DO-54.6  BALB/c  cOVA  d  BW5147  cOVA/I-A  d  jfOVA/I-A  d 
3DO-54.8  BALB/c  cOVA  d  BW5147  eOVA/I-A  a  jfOVA/I-A  a, qOVA/ 
LA  d, I-A  f, I.A  s 
4DO-11.7  BALB/c  cOVA  d  BW5147  cOVA/I-A  d  tOVA/I-A  d, wOVA/I-A  d 
3DT-18. l 1  BALB/c  (TG)AL  d  BW5147  (TG)AL/I-A  d  None 
AO-40.10  B 10.A  cOVA  a  FS6-14.13  cOVA/I-A  k  LA  b 
AODH-3.4  DBA/2  HgG  d  AO-40.10  cOVA/I-A  k  LA  b 1152  ISOLATION  OF  T  CELL  RECEPTOR  WITH  A  MONOCLONAL  ANTIBODY 
TABLE  II 
Characteristics of Subclones of DO- 11.10 
T cell hybridoma 
Approxi-  Units of IL-2 per milliliter 
mate  in response to  Percent specific 
number of  binding ±  SE to 
chromo-  OVA/I-A  a  OVA/I-A  b  Con A  OVA/I-Ad* 
somes 
DO- 11.10  74  >640  320  >640  42.5 ___ 5.6 
DO-t 1.10.3  69  <10  <10  >640  0.8 ±  1.8 
DO-II.10.7  69  <10  <10  >640  -1.4 ±  1.7 
DO-11.10.15  67  <10  <10  >640  0.7 ±  1.5 
DO- 11.10.24  68  >640  40  >640  48.0 +  5.8 
* Percent specific  binding was evaluated by binding radiolabeled hybridoma T  ceils to adherent A20-2J 
cells (a BALB/c B cell lymphoma; 33) pulsed with cOVA. Negative controls included unpulsed A20-2J 
cells. Percent specific binding is defined in Materials and Methods. 
hybridomas from immunized mice. The second method assumed that anti-receptor antibodies 
would block Ag/MHC  recognition by T  cells. Antisera and supernatants of B cell hybridomas 
were therefore included in 250-bd cultures containing 1.25 X  104hybridoma T  cells, Ag, and l0  S 
Ag-presenting  lymphoma  B  cells,  and  the  ability  of the  antibodies  to  interfere  with  IL-2 
production  was  thus  measured.  Mouse  antisera were  always  titrated  (29),  and  supernatants 
from primary B cell hybridomas were assayed at a  final concentration of 40%. 
Hybridomas  throught  to  be making antibody against Ag/MHC  receptors were expanded, 
retested,  frozen away,  and cloned, and the clones were reassayed.  Thus far, we have screened 
-3,000 primary hybridomas with this technique. One monoclonal antibody with anti-receptor 
activity has been identified. This antibody is described in this paper. 
Binding Assay.  The ability of T  cell hybridomas to bind to Ag/MHC  was measured in a  1- 
h  binding assay recently developed in our laboratory.  2 Adherent Ag-presenting B cell lympho- 
mas  or  hybridomas  (37)  were  plated  out  in  microcuhure  wells  overnight.  They  were  then 
washed and pulsed with Ag for 4  h  at  37°C.  After washing the cultures to remove unbound 
material, T  cells prelabeled with tritiated thymidine ([aH]TdR) were added and incubated for 
1 h  at 37°C.  Unbound T  cells were washed gently from the cultures and specific binding was 
estimated by liquid scintillation counting of [3H]TdR in the bound cells. In these experiments 
results were calculated as: percent specific binding --- [(counts per minute bound to specific Ag/ 
MHC  -  counts per minute bound nonspecifically)/(total counts per minute added  -  counts 
per minute bound nonspecifically)].  In assays for inhibition of binding, aliquots of antibody 
were added to cultures before T  cell hybrids. 
Production of Subclones of D0-11.10  Lacking Receptors  for cOVA/I-A d.  DO-11.10  was continu- 
ously cultured for 12 wk. At this point, the continuously cultured line and a sample of the same 
hybridoma freshly thawed from frozen stocks were challenged with concanavalin A  (Con A) or 
cOVA/I-A  a.  Although  both  samples  of  DO-11.10  responded  equally  well  to  Con  A,  the 
continuously cultured line made markedly less IL-2 in response to cOVA/I-A  a than the freshly 
thawed hybridoma. The continuously cultured line was therefore recloned at limiting dilution. 
Subclones were assayed for their ability to secrete IL-2 in response to cOVA/I-A  d, cOVA/I-A  h, 
and Con A. They were also tested for their ability to bind to adherent monolayers presenting 
cOVA/I-A  a (see Binding Assay, above).2 Some preliminary karyotyping was done. 
Sample results obtained with four of the subclones are shown in Table II. DO- 11. l0 and its 
subclone, DO-11.10.24, responded well to cOVA/I-A  a, cOVA/I-A  b, and Con A. They also had 
the ability to  bind  to  cOVA/I-Ad-presenting monolayers  in  a  1-h binding assay.  The  other 
three subclones, DO-11.10.3,  DO-11.10.7,  and DO-11.10.15,  lacked the ability to secrete IL-2 
in response to cOVA/I-A  a or cOVA/I-A  h. This was apparently because they had lost the ability 
to synthesize receptors for these moieties because they continued to secrete IL-2 in response to 
Con A, and also these subclones failed to bind to cOVA/I-Ad-bearing monolayers  in the  1-h 
2 Marrack,  P.,  B.  Skidmore,  and J.  W.  Kappler.  Binding of antigen-specific, H-2-restricted  T  cell 
hyhridomas to antigen-pulsed adherent cell monolayers. Manuscript submitted for publication. HASKINS ET  AL.  1153 
binding assay. Notably, loss of receptors did not seem to correlate with a  tremendous loss of 
chromosomes. None of the subclones differed from each other by more than a few chromosomes. 
Surface Labeling and Cell Lysis.  Membrane proteins were radioiodinated as previously de- 
scribed (38-40). Briefly, cells to be labeled were washed three times with phosphate-buffered 
saline (PBS) or with BSS and resuspended to a concentration of 5 ×  10  v cells/ml. The washed 
cells were combined with 0.5 mCi x25I-Na (specific activity, 17 Ci/mg; New England Nuclear, 
Boston, MA) and then transferred to a tube containing 50/~g of Iodo-gen (1,3,4,6-tetrachloro- 
3a,6a-diphenyl-glycoluril; Pierce Chemical Co., Rockford, IL). After 10 min at room temper- 
ature, cells were washed three times with PBS containing 10  -2 M  potassium iodide. 
Cell lysates were prepared by resuspending the washed cells (5  ×  10V/ml) in  lysis buffer 
containing 1% Nonidet P-40, 5 ×  10  -s M  phenylmethylsulfonylfluoride, and 0.05  M  iodoacet- 
amide in 0.1 M  Tris, pH 7.4, incubating the lysate at room temperature for 10 rain, and then 
centrifuging the lysate at  10,000 g for 20 min to remove nuclei and cellular debris. The extent 
of labeling was determined by measuring incorporation of the radioisotope into 10% trichloro- 
acetic acid-precipitable material. 
Immunoprecipitation.  Radiolabeled  material  was  incubated  with  monoclonal  antibody or 
control serum,  and  the  immune  complexes were  insolubilized by adsorption to  protein A- 
bearing Staphylococcus aureus according to the method of Kessler (41).  Immune complexes were 
washed extensively and then solubilized by addition of 200/~1 of electrophoresis loading buffer, 
followed by boiling and centrifugation to remove the bacteria. 
SDS-PAGE.  Samples analyzed in the unreduced state were made 50 mM in iodoacetamide 
before boiling; for reduced samples, 2-mercaptoethanol  (5% final concentration)  was added. 
Samples were than electrophoresed on  10% polyacrylamide gels containing SDS according to 
the  method  of Laemmli  (42).  For two-dimensional  SDS-PAGE,  nonreduced  samples were 
electrophoresed on a 5-10% gradient slab gel with 3% stacking gel in the first dimension. Strips 
were then cut out of the gel, placed in electrophoresis buffer with 2-mercaptoethanol, and after 
reduction were placed on  a  10%  gel to run  in the second dimension  (43,  44).  Radiolabeled 
polypeptides were revealed by autoradiography. 
Affinity  Chromatography.  Monoclonal antibodies (IgG2, murine subclass) were purified on 
protein A-Sepharose columns (45). Affinity chromatography matrices were prepared by chem- 
ically coupling the selected reagents to activated agarose beads (Pharmacia Fine Chemicals, 
Piscataway, N  J). 
Preparation of 125I-labeled Monoclonal Antibody.  Monoclonal antibody was purified from ascites 
fluid of mice growing the antibody-secreting hybridoma KJI-26.1  by binding to  protein A 
columns (45).  100/~g of the eluted antibody was labeled with 1.0 mCi of 125I by the chloramine 
T  method (46, 47). The labeling efficiency was 72%. Just before use the labeled antibody was 
spun in a Brinkmann microcentrifuge (Brinkmann Instruments, Inc., Westbury, NY) to remove 
aggregates. 
Results 
Anti-Id Antisera to  T  Cell Hybridomas.  In a  previous paper (29), we have described 
the production of antisera in congenic strains of mice to receptor material on antigen- 
specific, I  region-restricted T  cell hybridomas. In summary, immunizations with the 
T  cell hybridoma DO-11.10 (Table I), specific for cOVA/I-A d and cross-reacting with 
cOVA/I-A b, were carried out in three groups of mice:  (BALB/c ×  AKR)F1 animals, 
syngeneic to the hybridoma; (BALB.B X AKR)F1 animals, differing from the hybrid- 
oma  at H-2;  and  (C.B20  ×  AKR)F1 animals, differing from  the hybridoma at Igh. 
Mice were immunized multiple times and sera from individual animals were assayed 
for  anti-receptor antibodies, the activity of which was determined by the ability of 
antisera  to  inhibit  the production  of IL-2 by the  immunogen  T  cell hybridoma in 
response to Ag and Ag-presenting cells. Anti-receptor antibodies were produced in all 
three groups of mice, occurring with highest  frequency and  titer in the  (BALB.B  × 
AKR)F1 animals. The inhibitory antisera were idiotypically specific as they blocked 1154  ISOLATION OF T  CELL RECEPTOR  WITtt A MONOCLONAL ANTIBODY 
the response of DO-11.10, but did not affect responses of closely related hybridomas 
with  different  specificities.  The  interpretation  that  the  inhibitory antibodies  are 
directed  against  the  Ag/MHC  receptor(s)  on  DO-11.10  was  substantiated  by  the 
production  of antisera  against  another T  cell  hybridoma,  3DT-t8.11,  specific  for 
(TG)AL/I-A  d.  Like  the  anti-DO-11.10 antibodies, these  reagents only blocked  the 
response of the immunizing T  cell hybridoma and not closely related hybridomas. 
Examples  of these  results  obtained with  the  serum  of one  animal,  (BALB.B  × 
AKR)F1 mouse A, immunized with DO-11.10 are shown in Table III. The antiserum 
from this animal completely blocked the response of DO-11.10 to cOVA/I-A  d. The 
anti-cOVA/I-A  b response of the same T  cell hybridoma was also inhibited, although 
somewhat  less strikingly. The inhibitory antibodies were specific for a  determinant 
unique to DO-1 1.10 because they had no effect on the responses of closely related T 
cell hybridomas with similar gross, but different fine, specificities for Ag/MHC. 
Splenic B cells from this animal were used as fusion partners in an attempt to make 
monoclonal antibodies with  the  inhibitory properties  of  its  antiserum.  One  such 
monoclonal producer was found and characterized as described below. 
A Monoclonal  Antibody to the T  Cell Hybridoma  DO-11.10.  KJ 1-26 was the 26th hybrid 
well picked from the B cell fusion of spleen cells from (BALB.B X AKR)F1 mouse A 
immunized with  the  T  cell  hybridoma  DO-11.10.  Supernatant  from  the  primary 
culture of this hybrid completely inhibited the response of DO-11.10 to cOVA/I-A  a. 
The hybrid cells were therefore cloned by limiting dilution and the culture supernate 
from the cloned line KJ 1-26.1  was titrated for inhibitory activity in the response of 
DO-11.10 to cOVA/I-A  d. Inhibition of IL-2 production could still be easily detected 
with as  little as  1 /A of antibody-containing  supernate in 250 #1 of culture (Fig.  1). 
The cloned cells were injected intraperitoneally into pristane-treated, 500-rad-irradi- 
ated, BALB/c mice for the production ofascites fluid. As is also readily observable in 
Fig.  1,  the  ascitic  fluid  of KJ1-26.1  was  ~l,000-fold  more  effective  than  culture 
supernatant in blocking the cOVA/I-A  a response of DO-11.10. 
Classification  of  KJ1-26.1  for  immunoglobulin isotype  was  carried  out  by  an 
TABLE III 
Properties of Antisera from a (BALB.B  X  AKR)F~ Animal Immunized with 
DO-tl. lO 
T cell hybridoma 
Units per milliliter  Culture conditions  of IL-2 
Ag-pre-  Without  With 
Ag  senting  antisera  antisera* 
cells 
DO- 11.10  cOVA  It-2 a  320  < 10 
DO- 11.10  cOVA  t t-2  h  160  20 
3DO-36.6  cOVA  tt-2  d  160  80 
3DO-54.8  cOVA  tt-2  d  320  320 
AODt t-3.4  cOVA  1  t-2  a  160  80 
3DT- 18.11  (TG)  AI,  H-2  d  320  320 
* Pooled antisera  from various bleeds of  (BALB.B ×  AKR)FI  mouse A 
immunized with DO-11.10 were added at a final concentration of 2% to the 
IL-2 induction cultures. HASKINS ET  AL.  1155 
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FI6.  1.  Titration of inhibition of cOVA/I-A  a response of DO- 11.10 by the monoclonal antibody, 
K  J1-26.1.  Serial dilutions were made into microcuhure wells  of either culture supernate or ascites 
fluid  from KJI-26.1.  To each well  were added  DO-I 1.10 T  cell  hybrids (I05),  A20-2J-presenting 
cells  (10s), and  l mg/ml OVA. After 24 h IL-2 production in the wells was assessed  as described in 
Materials and Methods, The control response of DO-1 I. 10 was 2,560  U IL-2/ml and is represented 
by the dotted line. 
Ouchterlony analysis. Results showed that the monoclonal antibody was of the IgG2, 
subclass. 
Specificity of KJl-26.1 Monoclonal Antibody.  In Fig. 2, resuhs are shown from exper- 
iments run  to demonstrate the specificity of the monoclonal antibody. Ascites fluid 
was diluted  1:1,000 and aliquots were placed in microcuhure wells with DO-11.10 or 
closely related hybridomas. Ag and appropriate Ag-presenting ceils were then added 
and the resultant IL-2 production was measured. In contrast to the complete inhibition 
of DO-11.10 response  to  cOVA/I-A  d or cOVA/I-A  b,  KJ1-26.1  had  no effect  on  a 
hybridoma (AODH-3.4) with the same antigen specificity but different H-2 require- 
ments,  or  a  hybridoma  (3DT-18.11)  with  comparable  I  region  but  different  Ag 
specificity.  Even  more striking  were  the  results  obtained  with  various  hybridomas 
with  the same gross specificity for cOVA/I-A  d as  DO-11.10 but  with  different  fine 
specificities (Table I). In each case, no inhibition was seen in the presence of the K  J1- 
26.1  monoclonal antibody. 
The fact that KJ1-26.1 only inhibited responses of DO-11.10 suggested that it was 
recognizing a determinant unique to this T  cell hybridoma. Because IL-2 production 
by DO-11.10 in  response to Con A  was not  inhibited,  the antibody could not have 
been acting by suppression of IL-2 secretion. Moreover, KJ 1-26. i had no effect on the 
responses of other T  cell hybridomas specific for combinations including cOVA or I- 
A  d, which proves that the antibody probably was not acting by binding to cOVA or 
I-A  d.  The fact that  I-A  d was not a  target  for KJ1-26.1  was further substantiated  by 
the fact that DO-11.10 responses to cOVA/I-A  b were also blocked by this antibody. 
Thus,  the  most  reasonable  interpretation  of these  results  was  that  KJ1-26.1  was 
specific for all or part of the receptors for cOVA/I-A  d and cOVA/I-A  b on DO-11.10. 
Activity of KJ1-26.1  in Binding Assays.  Although the experiments  described in  the 
previous section were most easily explained by the binding of KJ 1-26.1 to Ag/MHC 
receptors on DO-11.10, we wished to test  its  activity more directly by measuring its 1156  ISOLATION OF T  CELL  RECEPTOR  WITH A  MONOCLONAL ANTIBODY 
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Fro.  2.  Specificity  of the  monoclonal  antibody KJ[-26.1.  Cell cukures  were  prepared with  or 
without antibody in microculture wells containing responder T  cell hybrids, antigen, and antigen- 
presenting cells. The properties of the T  cell h~brids used are shown  in Table I.  Presenting  cells 
were: I  d, A20-2J; I  b, C57BLt10  spleen cells; I , B10.A spleen cells. In cultures  being  tested  for 
inhibition of IL-2 production,  KJl-26.1  ascites fluid was used at a dilution of 1:1,000. Antibody- 
containing experiments are indicated by solid bars; cross-hatched bars represent controls without 
added antibody. 
ability to interfere with the binding of DO-11.10  to cOVA/I-A  d.  Radiolabeled DO- 
1 I. 10,  DO- 11.10.24  (a  cOVA/I-Ad-specific subclone of DO- 1 I. i0),  and  AODH-3.4 
cells were added to microculture plates containing adherent monolayers of A20-2J  (a 
BALB/c  lymphoma;  33,  34)  or  LK4.5  (a  B  cell  hybridoma  bearing  I k and  Id;  37) 
prepulsed with cOVA, or LB 15.13  (a B cell hybridoma bearing [b and Id; 37). Control 
wells  contained  lymphoma  or  hybridoma  cells pulsed  with  HgG  or  in  the  case  of 
AODH-3.4, A20-2J cells pulsed with cOVA. The assay is described in more detail in 
Materials and Methods. 2 
After 1 h  incubation at 37°C, nonadherent cells were gently washed away, and the 
numbers of adherent  DO-11.10  or AODH-3.4  cells were determined by scintillation 
counting.  Results were calculated as percent specific binding +  standard error (SE) 
and  are shown  in Table  IV.  KJ1-26.1  profoundly  affected the  ability of DO-11.I0 
and DO-11.10.24  to bind to cOVA/I-A  d, but had no significant effect on the binding 
of AODH-3.4  to  cOVA/I-A k or  LA  b.  These  results  suggest  that  the  antibody was 
interfering  specifically with  Ag/MHC  recognition  by  DO-II.10,  i.e.,  that  it  was 
binding to the receptors for this complex on the T  cell hybridoma. 
Enumeration  of Target Molecules for KJ1-26.1.  Efforts were made to find out approx- 
imately how many target molecules for KJ1-26.1  were borne by each  DO-11.10 cell. 
K j1-26.1  antibody was coupled to 125I as described in  Materials and  Methods.  The 
radiolabeled antibody was then titrated into microculture wells containing DO-11.10 HASKINS  ET  AL.  1157 
TABLB  IV 
Inhibition of Binding by KJ1-26.1 
T cell hybridoma 
Binding  Percent specific binding  Percent 
monolayer  +  SE*  inhibi- 
tion of 
With 
Ag  H-2  Alone  KJ1-26.1:~  binding 
DO- l 1.10  cOVA  d  22.3 ±  4.6  1.6 +  6.6  93 
DO-11.10.24  cOVA  d  48,0 zt: 5.8  5.0 ±  2.2  90 
AODH-3.4  cOVA  k  23.5 ±  1,9  23.6 ±  4.7  0 
AODH-3.4  --  b  33.0 +  4.5  29.3 ±  4.3  11 
* Percent specific binding is defined in Materials and Methods. 
:~ KJ1-26.1  ascites fluid was added at a  final concentration of 1% to binding 
assay wells. 
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FIG.  3.  Binding of 125I-labeled  KJ1-26.1  to  DO-If.10  and  3DT-18.11.  Microcuhure wells were 
prepared containing various amounts of I2Sl-labeled KJ1-26.1  in 50 btl of BSS containing 25% fetal 
calf serum. Three identical sets of wells received 5 ×  10  ~ DO-11.10  (O),  5 X  105 3DT-18.11  (O), or 
no cells in 20/d of BSS containing 25% fetal calf serum. After 2 h  at 0°C, all wells were harvested 
using an  automated cell harvestor (Otto Hiller, Madison, WI)  on glass fiber filters (presoaked in 
fetal calf serum and washed thoroughly with saline). Filters were counted and the net counts per 
minute of leSl-antibody bound  to  the cells was calculated, correcting for the counts per  minute 
bound to filters from wells in which no hybrid cells were added (which was ~ 10% of the counts per 
minute bound to filters from wells containing DO-11.10 ceils). A known quantity of the l~I-labeled 
protein was counted and these counts were used to convert the scale of counts per minute both to 
nanograms of antibody bound per 5 ×  l0  s cells and to molecules of antibody bound per cell. 
or 3DT-18.11 cells. After incubation, cells were washed and harvested onto glass fiber 
filters.  As shown  in  Fig.  3,  there  was  no specific binding of KJ1-26.1  antibody to 
3DT-18.11.  In contrast, binding to DO-11.10 increased with  increasing amounts of 
antibody added,  reaching a  plateau  of 2  ng/5  ×  105  ceils.  Results  indicated  that 
~15,000  KJ1-26.1  antibody  molecules  were  bound  to  each  DO-11.10  cell,  which 
suggests that  the  number of target  molecules on  DO-11.10 was the same order of 
magnitude. 
In a  second series  of experiments we checked the ability of 12SI-KJ  1-26.1 antibody 
to bind to a series  ofT cell hybridomas. As shown in Fig. 4, KJ1-26.1 bound to DO- 
I 1.10 and somewhat less well to DO-11.10.24, a cOVA/I-Ad-specific subclone of DO- 
11.10. The antibody did not bind to DO-11.10.3, DO-11.10.7, and DO-11.10.15, three 1 15)8  ISOLATION  OF  T  CELL  RECEPTOR  WITH  A  MONOCLONAL  ANTIBODY 
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125  F~G.  4.  Idiotypic binding of  "I-labeled KJ1-26.1.  Microcuhure  wells were prepared  containing 
of  I-labeled  KJI-26.1  as  in  Fig.  3.  Triplicate wells received  5  ×  105  of the  10  T  cell  300  ng  12s 
hybridoma clones shown (the properties of which are indicated in Tables I and II). An  1 Ith triplicate 
set  received  5  X  l0  s  A20-2J  B  [ymphoma  cells and  a  12th  set  received  no  cells.  Cultures  were 
incubated, harvested on filters, washed, and counted as in Fig. 3. The net counts per minute bound 
was calculated and  converted  to  molecules of 125I-KJl-26.1  bound  per cell also as  in  Fig.  3.  The 
results of this calculation are shown with the standard error. 
subclones of DO- 11.10  that had lost the ability to respond to or bind to cOVA/I-A  a 
or cOVA/I-A  b, but  which  retained  the ability to secrete IL-2 in  response to Con A 
(see Materials and Methods and Table II). 
We concluded  that  the ligand of KJ1-26.1  was present only on cells bearing Ag/ 
MHC  receptors  derived  from  DO-tl.10.  The  ligand  was  not  present  on  receptor- 
negative subclones of DO-11.10, or on other T  cell hybridomas with clonally related, 
but not identical specificities (Table I). The putative Ag/MHC receptors were present 
at  -15,000/DO-11.10  cell  and  about  5,000/DO-11.10.24  cell.  Other  results,  for 
example the  Ag/MHC  reactivity of DO-11.10.24  (Table  II), had  led  us  to suspect 
that DO- 11. t0.24 might bear fewer receptors per cell than DO- 11.10. 
hnmunoprecipitation  and SDS-PAGE Analysis of Molecules  Reacting with KJ1-26.1.  To 
identify the T  cell surface protein(s)  with which  the monoclonal antibody K J1-26.1 
reacts, cell lysates of 12'SI-labeled T  cell hybridomas were incubated with aliquots of 
KJ1-26.1 ascitic fluid or in some cases with purified KJ 1-26.1  antibody. The antigen- 
antibody complexes were harvested  with  formalin-fixed, protein  A-bearing S.  aureus 
and subsequently analyzed by SDS-PAGE. When  the K J1-26.1  immunoprecipitates 
of surface-labeled preparations  of either  DO-11.10  or 3DT-18.11  were analyzed by 
SDS-PAGE  (10%),  the  patterns  shown  in  Fig.  5  were  consistently  observed  in  six HASKINS  ET  AL.  1159 
FIG.  5.  K  J1-26.1  immunoprecipitates of surface-labeled  T  cell  hybridomas.  DO-I 1.10 or 3DT- 
18.11 were surface-labeled  with  1esI, lysed,  and  incubated with  25 ~g of purified  KJ1-26.1.  Ag- 
antibody complexes were precipitated with protein A and electrophoresed  on  10% SDS-PAGE gels 
under reducing (lanes  1 and 2) or nonreducing (lanes 3 and 4) conditions.  Lanes  1 and 3 contain 
precipitates from  DO-11.10,  lanes  2 and 4 contain precipitates from 3DT-18.11.  Molecular weight 
markers  (m lanes) are as follows: 97 = phosphorylase  B, 97,400; 69 = bovine serum albumin, 69,000; 
45 = ovalbumin, 45,000; 30 =  carbonic anhydrase, 30,000;  18 ~  lactoglobulin B, 18,400. 
Fic.  6.  Immunoprecipitation  of DO-11.10  or  variant  subclones  by  KJl-26.1.  Cell lysates  were 
prepared  from 125I-surface-labeled DO-11.10  or variant clones of this T  cell hybridoma. Immuno- 
precipitation was carried out using either the KJ1-26.1  ascites  (A) or normal rabbit serum (NRS) 
(B),  and  samples  were  analyzed  after  reduction  by  SDS-PAGE on  10%  gels  and  subjected  to 
autoradiography.  Material precipitated  from  DO-I 1.I0  is shown  in  lane  1, and  from its positive 
subclone,  DO-11.10.24,  in lane 5. Lanes  2-4 are patterns of immunoprecipitates from DO-11.10.3, 
DO-11.10.7,  and DO-1 l. 10. i5, respectively,  all of which are negative variants of DO-11.10. 
separate  experiments.  Immunoprecipitates  of  DO-11.10  analyzed  under  reducing 
conditions  were  resolved  into  three  major  bands  of radioactivity  corresponding  to 
molecules  with  apparent  molecular  weights  of  ~200,000,  ~70,000,  and  40-44,000, 
respectively (Fig. 5, lane  1).  Under  the same conditions,  the K J1-26.1  immunoprecip- 
i tate of 3DT-t 8. t 1 lysates showed major banding  in the 200,000 region, weak banding 
in the 70,000 region, and no product with an apparent  molecular weight of 40-44,000. 
The 200,000 and 70,000 bands were observed in the SDS-PAGE  patterns ofnonspecific 
immunoprecipitates  of both  DO-11.10  and  3DT-18.11  lysates  (data  not  shown,  but 
see  Fig.  6).  Pretreatment  of  the  lysates  with  staphylococci  greatly  reduced  the 1160  ISOLATION  OF T  CEI,I. RECEPTOR WITH A MONOCLONAL ANTIBODY 
appearance of the 200,000 and 70,000 bands in the patterns of the specific immuno- 
precipitates. The 40-44,000-mol wt product obtained with the KJ 1-26.1 immunopre- 
cipitation of DO-11.10 lysates was not influenced by the preclearance of the lysates 
with staphylococci. 
When the same immunoprecipitates were analyzed without prior reduction with 2- 
mercaptoethanol, a  band  of radioactivity corresponding to an  apparent  molecular 
weight of 80-90,000 was observed in the K j1-26.1  immunoprecipitate of DO-11. l0 
lysates but not of 3DT-18.11  lysates (Fig.  5, lanes 3 and 4). The bands in the higher 
molecular weight regions of the gel pattern seen in the immunoprecipitates of both T 
cell  hybridomas  were  due  to  material  nonspecifically  immunoprecipitated.  These 
results suggest that the KJ1-26.1-reactive T  cell surface component of the DO-11.10 
T  cell  hybridoma  is  an  80-90,000-mol  wt  protein  composed  of disulfide-bonded 
subunits of ~40-44,000. 
The reactivity of the KJ1-26.1  monoclonal antibody on surface-labeled DO-I 1.10 
and the subclones of this T cell hybridoma (Table II) were compared. In Fig. 6 (panel 
A) are illustrated the SDS-PAGE patterns of KJ 1-26.1 immunoprecipitates (reduced 
with 2-mercaptoethanol prior to electrophoresis) of cell lysates of DO-11.10 (lane  1), 
an Ag/MHC  receptor-bearing subclone, DO-11.10.24  (lane 5), and several receptor 
negative  subclones  (lanes  2-4).  The  40-44,000  protein  is  readily  observed  in  the 
patterns of the immunoprecipitates of DO-11.10 and DO-11.10.24 cell lysates, but is 
not  detected  in  the  immunoprecipitates  from  the  lysates of the  negative  variants. 
Again, the bands of radioactivity observed in the high molecular weight region (i.e., 
>70,000)  appear  to  represent  material  nonspecifically  bound  or  trapped  in  the 
immune complexes as these products can be resolved in the control immune precipi- 
tates (Fig.  6, panel B). 
Thus,  the  two  T  cell  hybridoma  lines  that  were  known  by  binding  and  IL-2 
production studies to bear receptors for cOVA/I-A  d were also able to bind KJ 1-26.1 
(Fig. 4) and yield 40-44,000-mol wt precipitates with the antibody, whereas the three 
cOVA/I-A  a  nonreactive  subclones  of DO-II.10  were  negative  in  all  these  assays, 
which strongly suggests that the 40-44,000-mol wt material represented all or part of 
the receptor(s) for cOVA/I-A  a on DO-11.10. Significantly less 40-44,000 material was 
precipitated by K  J1-26.1  from  DO-11.10.24  than  from DO-11.10  (Fig.  6).  Binding 
and IL-2 studies had also suggested that the subclone bore fewer cOVA/I-A receptors 
per cell than DO- 11.10. 
Further resolution of the KJ 1-26.1 immunoprecipitates from cell lysates was accom- 
plished by two-dimensional SDS-PAGE analysis (43, 44). For this purpose, samples in 
unreduced  form  were  electrophoresed  on  a  5-10%  gradient  slab  gel  in  the  first 
dimension.  Strips from this gel were excised, equilibrated  in electrophoresis sample 
buffer containing 5% 2-mercaptoethanol, and then loaded onto a  10% slab  gel and 
electrophoresed.  Under  these  conditions,  proteins  that  are  covalently  bonded  by 
disulfide bonding can be identified in the second dimension as spots that do not lie on 
the diagonal. The diagonal pattern is formed by proteins that  migrate in  the same 
fashion with or without prior reduction with 2-mercaptoethanol (i.e.,  noncovalently 
associated  products).  Fig.  7  shows  the  two-dimensional  gel  patterns  of K J1-26.1 
immunoprecipitated material from two separate experiments. In the first experiment, 
the  immunoprecipitates  from  DO-11.10  (Fig.  7A)  and  3DT-18.11  (Fig.  7B)  were 
compared and  in the second experiment, the immunoprecipitates of DO-11.10  (Fig. HASKINS ET AL.  1161 
FIG.  7.  Two-dimensional SDS-PAGE analysis of 125I-labeled membrane proteins immunoprecipi- 
tated with KJ 1-26.1. T cell hybridomas were 12SI-surface-labeled,  lysed, and precipitated with K  J 1- 
26.1 and protein A. Samples of each precipitate were electrophoresed in nonreduced form in the 
first, horizontal, dimension and in reduced form in the second, vertical, dimension. The autoradi- 
ograms shown represent the  results of two  separate experiments, the  first in  which KJ1-26.1 
immunoprecipitates from DO-11.10 (A)  and 3DT-18.11 (B)  were compared, and the second in 
which immunoprecipitates from DO-11.10 (C)  or  its  negative subclone, DO-II.10.3  (D)  were 
compared. The arrows in A and C point to the 40-44,000 mol wt protein(s). 
7 C)  and the negative variant DO- 11.10.3  (Fig.  7 D)  were compared.  In both of the 
patterns of the  K J1-26.1  immunoprecipitates of DO-11.10 cell lysates, a  prominent 
spot lying off the diagonal in a region corresponding io an apparent molecular weight 
of  40-44,000  can  be  seen.  The  vertical  position  of  this  product  (i.e.,  its  relative 
mobility in the first dimension) corresponds to an apparent molecular weight of 80- 
90,000 as anticipated from the one-dimensional  analysis of the unreduced and reduced 
immunoprecipitates (Fig. 5). Neither the 3DT- 18.11  nor the DO- 11.10.3 immunopre- 
cipitates shows the presence of the 40-44,000-mol wt product, although the proteins 
forming the diagonal pattern are identical to those in the diagonal seen in the DO- 
11.10 immunoprecipitate patterns. The dark-intense spot of higher molecular weight ! 162  ISOLATION OF T  CELL RECEPTOR WITH  A MONOCLONAL ANTIBODY 
Fro.  8.  Immunoprecipitation  using KJ1-26.1-conjugated Sepharose beads. A B cell lymphoma 
and T cell hybridomas were 12'5I-surface-labeled,  lysed, and immunoprecipitated by Sepharose beads 
conjugated either to KJ1-26.1 (A) or to HOPC-1  (B). Specifically bound, eluted products were 
analyzed after reduction on SDS-PAGE. Autoradiogram patterns are as follows: lane 1, A20-1.11, 
a BALB/c B cell lymphoma (33); lane 2, DO-11.10; and lane 3, DO-11.10.3, the negative variant 
of DO-11.10. 
that  lies  slightly  off the  diagonal  is  seen  in  all  the  gel  patterns  and  is  the  viral 
glycoprotein gp70, since preclearance of the lysates with a  rat anti-gp70 monoclonal 
reagent markedly reduces the appearance in subsequent KJ 1-26.1  immunoprecipitates 
(results  not shown). This gel system gives clear resolution of the covalent structure of 
the  KJ1-26.1-reactive  T  cell  component  and  its  subunit  structure.  It  is  not  clear 
whether  the  40-44,000  product  represents  a  single  molecular  species  or  muhiple 
components of similar size, and therefore, whether the covalent form is a  homodimer 
or a  heterodimer. 
hnmunoprecipitations  of  radiolabeled  cell  lysates  were  also  carried  out  using 
purified monoclonal antibody conjugated to Sepharose 4B beads.  In Fig. 8 are shown 
the SDS-PAGE autoradiograms of the labeled materials from three different cell lines: 
A20-1.11,  an  lad-expressing  B  cell  lymphoma  (33)  (lane  1),  DO-11.10  (lane  2),  and 
DO-11.10.3, the receptor negative subclone of DO-11.10 (lane 3).  Bound material was 
eluted  from immunoadsorbents consisting of K J1-26.1  antibody conjugated to Seph- 
arose 4B  (panel  A), or HOPC-1, a  T2a mouse myeloma protein, coupled to Sepharose 
4B  (panel  B).  The  materials  eluted  from  the  HOPC-1  immunoadsorbent  represent 
nonspecifically  bound  or  trapped  material  and  only  in  the  case  of  radiolabeled 
products  from  DO-11.10  cell  lysates  eluted  off the  KJ1-26.1  immunoadsorbent  is  a 
distinct  product  resolved  (i.e.,  the  40-44,000  protein).  This  species  is  not  detected 
either in the material  eluted  from the KJ 1-26.1  immunoadsorbent  from A20-1.11  or 
DO-11.10.3  cell  lysates  or from  the  materials  eluted  from the  HOPC-1  immunoad- 
sorbent. These patterns  are very similar  to those obtained using purified antibody or 
ascitic fluid and protein A-bearing staphylococci, but less nonspecific binding material 
is consistently observed using the bead-coupled antibody reagents. 
Discussion 
One of the problems  in  identifying antibodies  that  react  with  T  cell receptors  for 
Ag/MHC  has  been  the  difficulty  in  unequivocally  demonstrating  that  any  given HASKINS ET AL.  1163 
reagent is actually reacting with Ag/MHC receptors rather than some other surface 
molecule. Because of the cumbersome nature of assays for binding of T  cells to their 
Ag/MHC targets,  z putative anti-receptor antibodies have often been assayed for their 
ability to stimulate or block the response ofAg/MHC-specific T cells. Several perhaps 
misleading  and  currently  inexplicable  reactivities  have  thus  been  discovered.  For 
example, anti-Thy-1  antibodies  often seem  to stimulate T  cells  to  produce  IL-2 or 
divide  (48),  although  there is no reason to suppose any relationship between Thy-1 
and Ag/MHC recognition by T  cells. Several reagents have been reported to block T 
cell responses. These include Lyt-2, and OKT8 or Leu-2, which block the functional 
activity of cytotoxic T  cells in  mouse and man, respectively (49-51),  and OKT4 or 
Leu 3 (52), and a recently described equivalent in mouse (D. Wilde, D. Dialynas, and 
F. Fitch, personal communication), which blocks Ag reactivity of DR or I-restricted 
T  cells in man or mouse. The mapping of Lyt-2 near K  chains in mouse makes results 
with  this Ag particularly  intriguing.  However, the  fact  that  the targets of all these 
inhibitory antibodies do not seem to vairy in amino acid sequence or antigenicity on 
different  T  cell  clones  and  that  some  noninhibited  T  cell  lines  have  been  found 
suggests that these molecules do not actually comprise the variable portions of T  cell 
receptors for Ag/MHC, though they may be intimately involved with these polypep- 
tides. 
The production  of antibody that  is clone specific in  its ability to mimic or block 
Ag/MHC reactivity by T  cells is therefore an encouraging feature, because this leads 
us  to  hope  that  the  antibody  in  question  is  reacting  with  some  clone-specific, 
"idiotypic" molecule on the T  cell surface, presumably a part of its receptor. Several 
reports have been  published  of such  clone-specific antibodies  (53,  54)  although  no 
extensive  biochemical  studies  have yet  appeared.  We  have  been  producing  clone- 
specific antibodies in congenic mice immunized with cloned Ag/MHC-specific T  cell 
hybridomas; the monoclonal antibody KJ 1-26.1 discussed in this paper is the product 
of a B cell hybridoma derived from of one of these mice. 
There is every reason to suppose that  KJ1-26.1  is reacting with all or part of the 
receptor(s)  for  Ag/MHC  on  the  immunizing  T  cell  hybridoma  DO-11.10.  The 
antibody blocks IL-2 production  in response to Ag/MHC by this T  cell hybridoma 
but  no  others.  This  includes  T  cell  hybridomas  of  the  same  strain  derivation 
(BALB/c fused to BW5147)  and even of closely related but not identical specificities. 
The case would  probably be strengthened  by the use of another T  cell  hybridoma 
with the same fine specificity for Ag/MHC as DO-11.10. In this case we would predict 
that  KJI-26.1  might  have blocking activity.  Unfortunately,  DO-II.10 represents  a 
rather rare clonotype, defined by its cross-reaction with jfOVA/I-A  d and with cOVA/ 
I-A  b. We have not yet observed a second independent T  cell hybridoma with this fine 
specificity. 
The idea that KJ 1-26.1  reacts with a determinant expressed only by DO-11.10 was 
strengthened by binding and precipitation studies. The radiolabeled antibody failed 
to  bind  to  any of a  number of closely related  T  cell  hybridomas or to  precipitate 
material from any T cell hybridomas other than DO-11.10 and its Ag/MHC receptor- 
bearing  subclone,  DO-11.10.24.  Thus,  not  only  was  KJ1-26. l  unable  to  inhibit 
responses to Ag/MHC  by other T  cell hybridomas, but the determinant recognized 
by this antibody was apparently absent from their surfaces. 
Several other pieces of information suggested that KJ1-26.1  was binding to all or 1164  ISOLATION  OF T CELL RECEPTOR WITH A MONOCLONAL  ANTIBODY 
part of the Ag/MHC receptor on DO-11.10. First,  the antibody failed to block IL-2 
production by DO- 11.10 in response to Con A, which suggests that it interfered with 
Ag/MHC recognition rather than IL-2 secretion per se. Second, in  1-h binding assays 
the antibody blocked DO- 11.10 and DO-11.10.24 binding to cOVA-pulsed Id-bearing 
adherent  monolayers, but had no effect on the binding to Ag/MHC of a  control T 
cell  hybridoma. Third, the fact that  the antibody failed to block cOVA recognition 
by any of a  panel of cOVA-specific T  cell  hybridomas besides  DO-I 1.10 suggested 
that cOVA itself was not a  target of the antibody. The immunization protocol used 
to raise KJ 1-26.1 and its binding and immunoprecipitation properties of course also 
supported this idea.  Fourth, KJ1-26.1  did not seem to be acting by binding to H-2- 
encoded  determinants,  either  on  DO-11.10,  or on  Ag-presenting cells.  Because  the 
antibody was derived  from  (BALB.B ×  AKR)F1 cells  immunized with  a  (BALB/c 
X AKR) T  cell hybridoma, this was of course a possibility. KJ 1-26.1 failed to bind or 
precipitate material from the H-2d-bearing, Ia  +, Ag-presenting B cell lymphoma A20- 
2J, or any BALB/c-derived T cell hybridomas other than DO-11.10 and its derivative. 
Moreover, the molecular weight of the material precipitated from DO-11.10 was not 
similar to that of any known H-2 product of either class  1 or class 2 type. For example, 
no flz-microglubulin was precipitated, and on unreduced gels, an 80,000-mol wt dimer 
was  identified.  The  molecular weight  of the  precipitated  material,  and  its  unique 
expression on DO-11.10, also suggested that the antigen precipitated by KJ 1-26.1 was 
not  any of the  molecules commonly found on T  cells,  T200,  transferrin  receptors, 
lymphocyte functional  antigen-l,  Lyt-l, Lyt-2, Thy-1, or  the  murine equivalent  of 
OKT4 (55-58; D. Wilde, D. Dialynis, and F. Fitch, personal communication). 
Finally,  we  were  very  encouraged  to  find  that  K  J1-26.1  failed  to  bind  to  or 
precipitate  material  from subclones of DO-11.10 that were thought to have lost the 
ability to synthesize receptors for cOVA/I-A  d or cOVA/I-A  b. Because these subclones 
failed  to bind or respond to Ag/MHC but  continued to secrete IL-2 in  response to 
Con  A,  it  was  likely  that  they  had  lost  receptor  material,  probably  because  of 
chromosome loss, a relatively common event in hybridoma cells of all types. 
Taken together, these results strongly suggest that KJ 1-26. l reacts with the receptors 
for cOVA/I-A  d or cOVA/I-A  b on DO-11.10. There was therefore considerable interest 
in  the  material  precipitated  by this  antibody.  Our  gel  studies  showed clearly  that 
under nonreducing conditions, a  band of ~80-90,000 tool wt  was precipitated  that 
migrated at 40-44,000 tool wt under reducing conditions. This was most dramatically 
illustrated  by two-dimensional  gel  analysis  in  which  this  band  and  gp70 were  the 
only radiolabeled surface proteins of DO-11.10 present  in the immunoprecipitate to 
fall  below the  diagonal  line.  In  every case,  although most  of our precipitates  were 
contaminated  to some degree by the  major surface components known to be on T 
cells and T  cell hybridomas, e.g., T200 and gp70 (55, 59), the specific precipitation of 
material from DO-11.10 by K  J1-26.1 could be easily observed. More recently, the use 
of K  J1-26.1 affinity columns has allowed cleaner isolation of the material of interest. 
The reason for the nonspecific precipitation of other T cell surface moieties with KJ 1- 
26.1  was  not  entirely  clear.  Usually,  specific  precipitation  enhanced  nonspeeific 
"trapping,"  which  suggests  that  precipitation  of membrane  vesicles,  for  example, 
might be causing this effect. 
Molecules of the type precipitated by KJ 1-26.1 have been described before. Goding 
and  Harris  (60) described  a  disulfide-bonded  diffuse  spot  on  gels  of radiolabeled HASKINS ET AL.  1165 
thymocytes that  seemed to be associated  with  Lyt-2, but  which  had  the molecular 
weight properties of the molecule we have identified. More recently, Allison et al. (61) 
have isolated a similar molecule from a C57BL/Ka x-ray-induced T  cell lymphoma. 
Interestingly,  and  probably significantly,  in  their case  the  molecule  was  identified 
using a monoclonal antibody that reacted only with the molecule on the immunizing 
T  cell, which suggests that it might have been reacting with a  receptor (of unknown 
Ag/MHC  specificity) on the surface of the tumor. In this study, the 80,000-mol wt 
dimer was shown to be made up of two chains of slightly different molecular weights 
(39,000-41,000)  and different isoelectric focusing patterns.  The covalent form of the 
molecule  precipitated  by  K J1-26.1  may well  be  composed  of similar  subunits,  as 
suggested by the diffuse nature of the spots seen in gel patterns. 
The homology between  the molecule identified  by KJ1-26.1  and other molecules 
on the surface of or secreted by T  cells that bind free Ag is not obvious. In general, 
molecules of the latter type seem to be -70,000  mol wt dissociating to 45,000  and 
25,000 fragments. Several alternatives are possible. The 45,000 chain identified in Ag- 
binding  material  may be  similar  to  one  of the  ~40,000  chains  that  make  up  the 
molecule we and others (60, 61) have isolated. Alternatively, since most previous work 
has involved Ag-binding receptors, and the receptors on DO-11.10 have no apparent 
affinity for cOVA in  the absence of I-A  d or I-A  b, it  is possible that  two completely 
different  types  of receptors  are  being  studied  in  these  experiments.  The  apparent 
absence of VH determinants or MHC products in Ag/MHC  receptors of our T  cell 
hybridomas would support this  (28;  and N. R.  Roehm, K. Karjalainen, J.  Kappler, 
and P. Marrack, manuscript in preparation). 
Many questions have yet to be answered in our studies. Does KJ1-26.1 identify the 
entire  receptor(s)  for Ag/MHC  on  DO-11.10  or is just  a  portion  of the  receptor(s) 
precipitated? Is the structure of the receptor(s) on DO-11.10 for Ag/I-A identical to 
the structure of receptors on other T  cells specific for Ag/class I molecules or Ag/I-E? 
What are the differences in sequence between receptor material on DO-11.10 and on 
T  cell lines of different specificities? These questions will occupy future work on the 
subject. 
Summary 
An  antibody-secreting B  cell hybridoma, KJ1-26.1, has been prepared from mice 
immunized with the T cell hybridoma DO- 11.10, which recognizes chicken ovalbumin 
in association with I-A  a (cOVA/I-Aa). KJ 1-26.1 blocks I-restricted antigen recognition 
by DO-11.10 and a  subclone of this T  cell hybridoma, DO-11.10.24,  which  has the 
same specificity for cOVA/I-A  a  as  its  parent.  KJ1-26.1  does  not  block I-restricted 
antigen recognition by any other T  cell hybridoma tested, including a  number of T 
cell hybridomas closely related to DO-11.10, with similar, but not identical, specific- 
ities for antigen/I. Moreover, KJ1-26.1  binds to DO-11.10 and DO-11.10.24, but not 
to any other T  cell hybridomas tested,  including  three subclones of DO-11.10  that 
have lost the ability to recognize cOVA/I-A  a. Thus, in every regard KJ 1-26.1 appears 
to be binding to all or part of the receptors for antigen/I on the T  cell hybridoma 
DO-11.10. 
K J1-26.1  appears to bind  to  ~ 15,000  molecules/cell on the surface of DO-11.10. 
The antibody precipitates an 80,000 dimer from the cells, which on reduction migrates 
as 40-44,000 monomers. The receptor(s) for antigen/I on DO-11.10 therefore includes 1166  ISOLATION OF T  CELL RECEPTOR  WITH A MONOCLONAL ANTIBODY 
molecules with these properties. 
Note added in proof." Another molecule which is similar to that precipitated by KJ 1- 
26.1  has come to our attention. Reinherz et al.  (Reinherz, E. L., S. C. Meuer, and S. 
F. Schlossman. 1983. Immunol.  Today (Amst.).  4:5) have recently reported clone-specific 
monoclonal antibodies which  precipitate glycoprotein chains of 49,000  and 43,000 
mol wt from cloned human cytotoxic T  cells. 
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and Ella Kushnir for excellent technical assistance, and to  Edna Squillante for  her patient 
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